The ureteroscopy devices market stands on the cusp of a dynamic transformation, propelled by the global upsurge in kidney stone cases and ureteral cancer diagnoses. According to recent projections, the market is expected to grow by USD 297.8 million from 2023 to 2028, registering a healthy compound annual growth rate (CAGR) of 5.36%. This growth reflects both rising disease incidence and an increasing preference for minimally invasive surgical interventions. As we explore the 2025–2029 outlook, several converging factors—from technological advancements to shifting demographics and regional healthcare infrastructure improvements—are shaping the future of ureteroscopy devices..For more details about the industry, get the PDF sample report for free
At the heart of the ureteroscopy devices market’s expansion is the growing prevalence of urolithiasis (urinary stone disease) and ureteral cancer. These conditions are particularly rampant among the geriatric population and those with comorbidities such as Type 2 diabetes and coronary artery disease. In the U.S. alone, CDC data reported that approximately 6 million adults were diagnosed with kidney disease in 2018, while the National Kidney Foundation states over 11% of Americans will experience kidney stones in their lifetime. These staggering figures spotlight the increasing need for high-performance urological tools to enhance diagnostic accuracy and treatment efficiency.
Moreover, elective surgeries—particularly urological ones—are resurging post-COVID, with hospitals and ambulatory surgical centers investing in next-gen equipment to meet rising patient demand. This momentum is further fueled by technological innovation, including the development of flexible and semi-rigid ureteroscopes, high-definition digital imaging capabilities, and disposable devices that reduce cross-contamination risk.
Among the end-user categories, hospitals dominate the ureteroscopy devices market. In 2018, the hospital segment was valued at USD 500.6 million and has continued to show consistent growth. Hospitals are uniquely positioned to perform complex urological procedures due to their capacity, skilled personnel, and integrated imaging technologies. With hybrid operating rooms becoming more prevalent, hospitals now provide the optimal environment for conducting precise, minimally invasive surgeries that ureteroscopy entails.
Ambulatory surgical centers are another emerging frontier, particularly in developed markets where cost-efficiency and patient turnaround times are top priorities. Their increasing adoption of advanced ureteroscopy technologies reflects broader market shifts toward outpatient procedures.
From a product standpoint, flexible ureteroscopes are expected to witness robust adoption owing to their maneuverability and ability to access complex anatomical pathways. These are especially crucial for treating patients with multiple or unusually positioned kidney stones. Semi-rigid ureteroscopes, while slightly more limited in reach, offer cost-effective solutions for simpler procedures and remain vital in lower-tier healthcare settings.
Get more details by ordering the complete report
Geographically, North America is poised to contribute 43% of global market growth through 2028, with the U.S. and Canada serving as the primary drivers. The region benefits from high healthcare expenditure, sophisticated hospital infrastructure, and favorable reimbursement policies that encourage the adoption of advanced ureteroscopy devices. The integration of digital ureteroscopes and hybrid ORs in U.S. hospitals is a testament to how innovation and policy can drive uptake in medical technologies.
Asia, on the other hand, represents an exciting but underpenetrated market. Countries like China and India are investing heavily in expanding their healthcare infrastructure, especially in urban and tier-two cities. The region’s large population base, rising income levels, and growing awareness of minimally invasive procedures present a significant opportunity for global device manufacturers looking to diversify their geographic footprint.
International organizations such as the WHO are also playing a role by supporting healthcare development initiatives, particularly in Southeast Asia and parts of the Middle East and Africa. These investments could help bridge the access gap and stimulate adoption in emerging markets where traditional open surgeries still dominate.
Despite its positive trajectory, the ureteroscopy devices market is not without its challenges. Chief among them is cost. Advanced ureteroscopes, especially flexible and digital variants, come with high acquisition and maintenance costs. For many healthcare providers in low- and middle-income countries, these expenses remain a significant barrier.
Reimbursement remains another complex variable. While the scenario is improving, disparities between regions and providers still affect the pace of adoption. Moreover, there is a notable shortage of skilled urologists trained to handle advanced equipment, further impeding market expansion in certain areas.
That said, technological innovation continues to serve as both a differentiator and enabler. The rise of disposable ureteroscopes is a case in point. These devices not only reduce the risk of infection but also eliminate reprocessing costs, making them an attractive option for high-volume hospitals and ambulatory centers.
Get more details by ordering the complete report
Looking ahead to 2025–2029, we anticipate the ureteroscopy devices market to evolve in response to both clinical and economic imperatives. Here are some key trends expected to shape its future:
Increased Adoption of Disposable Devices: Infection control, especially in the post-COVID landscape, is becoming a priority. Disposable ureteroscopes that offer high-quality imaging and performance without reprocessing risks will see broader adoption.
Integration with Imaging Technologies: Hybrid ORs and digital platforms that combine ureteroscopy with real-time imaging will become standard in major hospitals. This will improve diagnostic accuracy and patient outcomes.
Focus on Emerging Markets: Manufacturers will target Asia-Pacific and Latin America for expansion, leveraging local partnerships and government incentives to penetrate these high-growth markets.
Telehealth and Online Sales: As patients become more health-conscious and digitally literate, the role of online healthcare platforms in facilitating device procurement and pre-operative consultations will grow.
AI-Enhanced Decision Support: AI algorithms may soon assist in image interpretation during ureteroscopy procedures, improving accuracy and reducing operator dependency.
The ureteroscopy devices market is witnessing robust expansion, fueled by the increasing incidence of kidney stones, ureteral cancer, and various urological disorders. The growing demand for minimally invasive treatment options has driven the adoption of advanced tools such as flexible ureteroscope and semi-rigid ureteroscope, particularly across hospital equipment providers and ambulatory surgery centers. The use of endoscopic procedures for conditions affecting the urinary tract, including stone removal, ureteral strictures, and ureteral tumors, is becoming standard practice. Techniques like laser lithotripsy and stone fragmentation offer effective, low-recovery-time solutions for urinary stones and renal calculi. As part of a comprehensive approach, the integration of ureteral stents, ureteral access tools, and both flexible endoscope and rigid ureteroscope devices are enhancing procedural efficiency and patient outcomes. Moreover, tools for ureteral blockage management are playing a vital role in modern urological surgery, addressing complications without resorting to open surgery.
For manufacturers and healthcare providers, the next five years offer a strategic window of opportunity. Here are key takeaways:
Invest in R&D for Cost-Effective Innovation: Bridging the affordability gap will be crucial for gaining market share in developing countries. Manufacturers should prioritize product lines that balance cost with functionality.
Build Training Programs for Skilled Personnel: Device makers can collaborate with hospitals and educational institutions to create specialized training modules, increasing the talent pool capable of using advanced ureteroscopes.
Leverage Digital Channels: Whether for marketing, telehealth integration, or online device distribution, digital platforms can drive awareness and streamline the patient pathway.
Collaborate with Policymakers: Engaging in policy discussions around reimbursement and infection control can help shape a favorable regulatory environment for market growth.
Get more details by ordering the complete report
Recent research highlights a significant shift toward incorporating cutting-edge imaging technology and high-definition imaging capabilities in ureteroscopy devices. The use of digital ureteroscope systems enables enhanced visualization, critical for procedures such as stone retrieval and the treatment of ureteral tumors. The market is also seeing rising preference for single-use ureteroscope and disposable ureteroscope devices due to their advantages in infection control and operational efficiency, compared to traditional reusable ureteroscope models. Technological advancements like digital imaging, advanced optics, and sophisticated optical systems are transforming endourology procedures, especially in urologic endoscopy targeting the renal pelvis and renal papillae. Furthermore, improved endoscopic imaging, the growing adoption of percutaneous access, and the development of ureteral dilators are key components of modern stone management strategies. These innovations support more precise stone extraction and significantly enhance patient care across a spectrum of urological interventions.
In summary, the ureteroscopy devices market from 2025 to 2029 is expected to experience steady, innovation-driven growth, underpinned by demographic trends, increasing disease burden, and an expanding footprint of minimally invasive procedures. While cost and workforce constraints persist, the opportunities outweigh the risks, especially for stakeholders willing to invest in smart, scalable, and inclusive solutions. As urological health becomes a global priority, ureteroscopy is poised to play a pivotal role in the next era of patient-centric care
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
